Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients.

ABSTRACT:

Objectives

Traditional contrast-enhanced methods for scanning blood vessels using magnetic resonance imaging (MRI) or CT carry potential risks for patients with advanced kidney disease. Ferumoxytol is a superparamagnetic iron oxide nanoparticle preparation that has potential as an MRI contrast agent in assessing the vasculature.

Methods

Twenty patients with advanced kidney disease requiring aorto-iliac vascular imaging as part of pre-operative kidney transplant candidacy assessment underwent ferumoxytol-enhanced magnetic resonance angiography (FeMRA) between December 2015 and August 2016. All scans were performed for clinical indications where standard imaging techniques were deemed potentially harmful or inconclusive. Image quality was evaluated for both arterial and venous

SUBMITTER: Stoumpos S 

PROVIDER: S-EPMC5717122 | biostudies-literature | 2018 Jan

REPOSITORIES: biostudies-literature